Certain Warrants of Cadrenal Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 20-JAN-2024. These Warrants will be under lockup for 365 days starting from 20-JAN-2023 to 20-JAN-2024.

Details:
The company has agreed to a 12 -month ?lock -up ? from the closing of this offering, during which, without the prior written consent of Boustead Securities, LLC, will not issue, sell or register with the SEC (other than on Form S -8 or on any successor form) with respect to any equity securities (or any securities convertible into, exercisable for or exchangeable for any equity securities), except for (i) the issuance of the shares of common stock offered pursuant to the prospectus; and (ii) the issuance of shares of common stock pursuant to existing equity incentive or bonus plan as described in the registration statement of which this prospectus forms a part.